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Abstract
Purpose Choline-containing dietary phospholipids,
including phosphatidylcholine (PC), may function as anti-
inflammatory substances, but the mechanism remains lar-
gely unknown. We investigated the effects of L-alpha-
glycerylphosphorylcholine (GPC), a deacylated PC deriv-
ative, in a rodent model of small intestinal ischaemia–
reperfusion (IR) injury.
Methods Anaesthetized Sprague-Dawley rats were divi-
ded into control, mesenteric IR (45 min mesenteric artery
occlusion, followed by 180 min reperfusion), IR with GPC
pretreatment (16.56 mg kg-1 GPC i.v., 5 min prior to
ischaemia) or IR with GPC post-treatment (16.56 mg kg-1
GPC i.v., 5 min prior to reperfusion) groups. Macrohae-
modynamics and microhaemodynamic parameters were
measured; intestinal inflammatory markers (xanthine oxi-
doreductase activity, superoxide and nitrotyrosine levels)
and liver ATP contents were determined.
Results The IR challenge reduced the intestinal intra-
mural red blood cell velocity, increased the mesenteric
vascular resistance, the tissue xanthine oxidoreductase
activity, the superoxide production, and the nitrotyrosine
levels, and the ATP content of the liver was decreased.
Exogenous GPC attenuated the macro- and microcircula-
tory dysfunction and provided significant protection against
the radical production resulting from the IR stress. The
GPC pretreatment alleviated the hepatic ATP depletion, the
reductions in the mean arterial pressure and superior
mesenteric artery flow, and similarly to the post-treatments
with GPC, also decreased the xanthine oxidoreductase
activity, the intestinal superoxide production, the nitroty-
rosine level, and normalized the microcirculatory
dysfunction.
Conclusions These data demonstrate the effectiveness of
GPC therapies and provide indirect evidence that the anti-
inflammatory effects of PC could be linked to a reaction
involving the polar part of the molecule.
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Introduction
Ischaemia–reperfusion (IR) contributes to the pathology of
many human diseases [1], and experimental IR models
offer rapid screening tools for studying antigen-indepen-
dent inflammatory reactions. The high reproducibility and
the specificity of these reactions to pro-oxidant and
inflammatory factors or to their receptors make these
models well-accepted and widely used, because the effi-
cacy of prophylactic or therapeutic treatment of gastroin-
testinal inflammation can adequately be evaluated in these
protocols [2–5]. Acute IR models are typically character-
ized by the release of soluble inflammatory mediators,
cellular and subcellular functional changes including the
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activation of polymorphonuclear (PMN) leucocytes and the
production of, among others, reactive oxygen and nitrogen
species [6, 7]. Anti-inflammatory therapy mainly focuses
on providing protection against the harmful consequences
of PMN reactions [8] and on the oxidative and nitrosative
stress responses to mitigate the damage to the affected
tissues.
The nutritional status is generally considered as an
important factor in the development of surgical complica-
tions, and dietary regimens hold some promise of limiting
inflammation. Phosphatidylcholine (PC) is an essential
component of biomembranes and endogenous surface-
coating substances, and it is well established that the main
elements of IR-induced tissue injuries include lipid per-
oxidation and the loss of membrane-forming phosholipid
bilayers [9]. Likewise, it has been shown that a reduced PC
content of the intestinal mucus plays significant roles in the
development of inflammatory bowel diseases [10]. Inter-
estingly, a number of data suggest that choline-containing
phospholipids, including PC, may function as anti-inflam-
matory substances under highly oxidizing IR conditions.
Several studies have indicated that exogenous PC inhibits
leucocyte accumulation [11, 12] and the generation of
inflammatory cytokines [13], and dietary PC administration
has been demonstrated to provide protection against
experimental neuroinflammation, arthritis and pleurisy [12,
14, 15] in rodents. Nevertheless, the specific mechanism of
action of PC is still not known with certainty, and the
question arises as to which of the moieties in the PC
molecule are of critical significance in the reduction of the
leucocyte responses and pro-inflammatory signal
production.
The PC molecule is composed of a choline head group
and glycerophosphoric acid, with a variety of saturated and
unsaturated fatty acids; given their potent bioactions, lipids
may be pro-inflammatory or deactivate inflammatory
pathway signalling in vivo [16, 17] and can possibly
influence tissue damage. On the other hand, emulsions
containing deacylated phospholipid derivatives do not
induce endoplasmic reticulum stress or the activation of
inflammatory pathway signalling [17]. L-alpha-glycer-
ylphosphorylcholine (GPC) is a water soluble, deacylated
PC intermediate which may be hydrolyzed to choline and
can possibly be used for the resynthesis of PC [18].
Interestingly, significantly lower concentrations of hepatic
GPC have been reported after experimental haemorrhagic
shock, a prototype of systemic IR, with recovery to the
baseline only 24 h later [19].
All these lines of research converge in suggesting that
GPC would be efficacious in influencing the inflammatory
response. We therefore assessed the biochemical and cir-
culatory effects of exogenous GPC treatment in a rat model
of mesenteric IR-induced intestinal inflammation, and
postulated that the results can provide indirect in vivo data
towards an understanding of the mechanism of anti-
inflammatory action of PC therapy.
Methods and materials
Animals
The experiments were performed on 32 adult male Spra-
gue–Dawley rats (250–300 g) housed in plastic cages in a
thermoneutral environment (21 ± 2 C) with a 12-h dark–
light cycle. Food and water were provided ad libitum. The
experimental protocol was approved by the Ethical Com-
mittee for the Protection of Animals in Scientific Research
at the University of Szeged (approval no. V./148/2013) and
followed the National Institutes of Health (Bethesda, MD,
USA) guidelines on the care and use of laboratory animals.
Experimental protocol
The animals were randomly allocated into four groups
(n = 8 each): a control, sham-operated group, a group that
participated in intestinal IR, and groups that took part in IR
with GPC pretreatment (GPC ? IR) or in IR with GPC
post-treatment (IR ? GPC). The GPC (MW: 257.2, Lipoid
GmbH, Ludwigshafen, Germany) was administered intra-
venously (i.v.) in a dose of 16.56 mg kg-1 bw, as a
0.064 mM solution in 0.5 ml sterile saline. These dosage
conditions were based on the data of previous investiga-
tions with PC; this dose was equimolar with the effective,
anti-inflammatory dose of PC (MW: 785; 0.064 mM,
50 mg (kg bw)-1, i.v.) in rodents [20, 21]. The GPC pre- or
post-treatment was applied once, either directly before the
ischaemic period or immediately after the ischaemia,
before the start of reperfusion (the iv. route offers exact
dosing and timing and faster absorption, which are essen-
tial factors in shorter experimental protocols).
The animals were anaesthetized with sodium pentobar-
bital (50 mg (kg bw)-1, intraperitoneally) and placed in a
supine position on a heating pad. Tracheostomy was per-
formed to facilitate spontaneous breathing, and the right
jugular vein was cannulated with polyethylene 50 tubing
for central venous pressure measurements and Ringer’s
lactate infusion (10 ml kg-1 h-1) during the experiments.
The right common carotid artery was cannulated with
polyethylene 50 tubing for mean arterial pressure and heart
rate measurements.
After midline laparotomy, the animals in groups IR,
GPC ? IR, and IR ? GPC were subjected to 45 min
ischaemia by occlusion of the superior mesenteric artery
with an atraumatic vascular clamp. Forty-five min after the
start of the ischaemic insult, the vascular clamp was
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removed and the intestine was reperfused. The superior
mesenteric artery blood flow was measured continuously
with an ultrasonic flowmeter (Transonic Systems Inc.,
Ithaca, NY, USA) placed around the artery. The abdomen
was temporarily closed, and the intestine was reperfused
for 180 min. In the sham-operated control group, the ani-
mals were treated in an identical manner except that they
did not undergo clamping of the artery.
After 180 min of reperfusion, tissue samples were taken
from the liver to determine the ATP content, and biopsies
were taken from the ileum to examine the tissue nitroty-
rosine and superoxide (SOX) production and the xanthine
oxidoreductase (XOR) activity.
Haemodynamic measurements
The mean arterial pressure and superior mesenteric artery
blood flow signals were monitored continuously and reg-
istered with a computerized data-acquisition system
(SPELL Haemosys; Experimetria Ltd., Budapest, Hun-
gary). The mesenteric vascular resistance was calculated
via the standard formula (mesenteric vascular resis-
tance = (mean arterial pressure-central venous pressure)/
superior mesenteric artery flow).
Intravital video-microscopy
The intravital orthogonal polarization spectral imaging
technique (Cytoscan A/R, Cytometrics, PA, USA) was
used for non-invasive visualization of the serosal micro-
circulation of the ileum 3–4 cm proximal from the caecum.
This technique utilizes reflected polarized light at the
wavelength of the isobestic point of oxy- and deoxyhae-
moglobin (548 nm). As polarization is preserved in
reflection, only photons scattered from a depth of
2–300 lm contribute to image formation. A 109 objective
was placed onto the serosal surface of the ileum, and
microscopic images were recorded with an S-VHS video
recorder 1 (Panasonic AG-TL 700, Panasonic, NJ, USA).
Quantitative assessment of the microcirculatory parameters
was performed offline by frame-to-frame analysis of the
videotaped images. The red blood cell velocity (RBCV,
lm s-1) changes in the post-capillary venules were deter-
mined in three separate fields by means of a computer-
assisted image analysis system (IVM Pictron, Budapest,
Hungary). All microcirculatory evaluations were per-
formed by one investigator (E.T.).
ATP measurement
The tissue handling was performed according to the
description of Lamprecht and Trautschold [22]. The liver
samples were cooled in liquid nitrogen and stored at
-70 C until assays. The tissue was weighed, placed into a
threefold volume of trichloroacetic acid (6 % w/v),
homogenized for 1 min, and centrifuged at 5,000 g. After
adjustment of the pH to 6.0 with saturated K2CO3 solution,
the reaction mixtures were prepared by the addition of
100 ll of ATP assay mix (containing firefly luciferase,
luciferin, MgSO4, EDTA, DTT, and BSA in a Tricine
buffer; Sigma-Aldrich GmbH, Munich, Germany) to
100 ll of fivefold-diluted sample. After the sample prep-
aration, the ATP content was immediately determined by
the measurement of luciferase chemiluminescence
according to the method of Chen and Cushion [23], using a
luminometer (LUMAT LB 9507, Berthold Technologies,
GmbH, Bad Wilbad, Austria) [24]. The ATP levels were
calculated with the aid of a standard ATP calibration curve
(Sigma-Aldrich GmbH, Munich, Germany), and the data
were referred to the sample weights.
Intestinal SOX production
The level of SOX production in freshly minced intestinal
biopsy samples was assessed by the lucigenin-enhanced
chemiluminescence assay of Ferdinandy et al. [25]. Briefly,
approximately 25 mg of intestinal tissue was placed in
1 ml of Dulbecco’s solution (pH 7.4) containing 5 lM
lucigenin. The manipulations were performed without
external light 2 min after dark adaptation. Chemilumines-
cence was measured at room temperature in a liquid scin-
tillation counter by using a single active photomultiplier
positioned in out-of-coincidence mode, in the presence or
absence of the SOX scavenger nitroblue tetrazolium
(20 ll). Nitroblue tetrazolium-inhibited chemilumines-
cence was considered an index of intestinal SOX
generation.
Xanthine oxidoreductase (XOR) activity
Colon and ileum tissue samples were kept on ice until
homogenized in phosphate buffer (pH = 7.4) containing
50 mM Tris–HCl (Reanal, Budapest, Hungary), 0.1 mM
EDTA, 0.5 mM dithiothreitol, 1 mM phenylmethylsul-
fonyl fluoride, 10 lg ml-1 soybean trypsin inhibitor, and
10 lg ml-1 leupeptin. The homogenate was loaded into
centrifugal concentrator tubes and examined by fluoro-
metric kinetic assay on the basis of the conversion of
pterine to isoxanthopterin in the presence (total XOR) or
absence (xanthine oxidase activity) of the electron-acceptor
methylene blue [26].
Intestinal nitrotyrosine level
Free nitrotyrosine, as a marker of peroxynitrite generation,
was measured by enzyme-linked immunosorbent assay
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(Cayman Chemical; Ann Arbor, MI, USA). Small intesti-
nal tissue samples were homogenized and centrifuged at
15,000 g. The supernatants were collected and incubated
overnight with anti-nitrotyrosine rabbit IgG and nitrotyro-
sine acetylcholinesterase tracer in precoated (mouse anti-
rabbit IgG) microplates, followed by development with
Ellman’s reagent. Nitrotyrosine content was normalized to
the protein content of the small intestinal homogenate and
expressed in ng mg-1.
Statistical analysis
Data analysis was performed with a statistical software
package (SigmaStat for Windows, Jandel Scientific, Erk-
rath, Germany). Due to the non-Gaussian data distribution,
nonparametric methods were used. Friedman repeated
measures analysis of variance on ranks was applied within
groups. Time-dependent differences from the baseline for
each group were assessed by Dunn’s method. Differences
between groups were analyzed with Kruskal–Wallis one-
way analysis of variance on ranks, followed by Dunn’s
method for pairwise multiple comparison. In the Figures
and Results, median values (M), and 75th (p75) and 25th
(p25) percentiles are given. Values of p \ 0.05 were con-
sidered statistically significant. *p \ 0.05 relative to the
baseline value (within groups), #p \ 0.05 relative to the IR
group, xp \ 0.05 relative to the sham-operated control
group and @p \ 0.05 relative to the GPC ? IR group.
Results
Haemodynamics
There were no significant changes in the haemodynamic
parameters during the experiment as compared with the
baseline values in the sham-operated group. A decreasing
tendency in mean arterial pressure was found in all IR
groups as compared with the sham-operated group (M:103;
p25:97.5; p75:115), and it remained at this low level until
the end of the experiment (IR group: M:88; p25:82;
p75:94; IR ? GPC: M:73; p25:67; p75:85). Mean arterial
pressure was elevated in the GPC ? IR group (M:93;
p25:85; p75:101) (Fig. 1). There was no statistically sig-
nificant difference in heart rate between the different
groups during the experiment (data not shown).
In the IR group (M:19.6; p25:13.7; p75:26.4), there was
a significant elevation in mesenteric vascular resistance
relative to the control value (M:5.8; p25:4.4; p75:6.7) up to
225 min of the reperfusion. This parameter exhibited a
pronounced reduction in the GPC ? IR group (M:9.7;
p25:8.1; p75:12.9) and a tendency to diminish in the
IR ? GPC group (M:10.3; p25:9.2; p75:11.6) (Fig. 2).
After the ischaemia, the superior mesenteric artery flow
was significantly reduced in the IR group (M:4.08;
p25:3.24; p75:5.4) relative to the sham-operated group
(M:14.52; p25:11.7; p75:17.99), but this difference was not
observed in the IR ? GPC group (M:6.67; p25:5.8;
p75:7.56). Moreover, there was an unequivocal tendency
for this parameter to increase in the GPC ? IR group
Fig. 1 Mean arterial blood pressure changes during intestinal
ischaemia–reperfusion (IR). The empty circles joined by a continuous
line relate to the sham-operated group, grey triangles to the IR group,
empty diamonds to the glycerylphosphorylcholine (GPC)-pretreated
group, and empty squares to the GPC-post-treated group. Median
values and 75th and 25th percentiles are given. *p \ 0.05 relative to
the baseline value (within groups); xp \ 0.05 relative to the sham-
operated control group
Fig. 2 Mesenteric vascular resistance changes during the experi-
ments. The empty circles joined by a continuous line relate to the
sham-operated group, grey triangles to the ischaemia–reperfusion
(IR) group, empty diamonds to the glycerylphosphorylcholine (GPC)-
pretreated group, and empty squares to the GPC-post-treated group.
Median values and 75th and 25th percentiles are given. *p \ 0.05
relative to the baseline value (within groups); xp \ 0.05 relative to the
sham-operated control group
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(M:7.53; p25:5.65; p75:9.14) as compared with the IR
group (Fig. 3).
Microcirculation
The RBCV of the serosa was examined as a quantitative
marker of the ileal microcirculatory condition. The RBCV
was significantly decreased in the IR group (M:660;
p25:469; p75:706) as compared with the sham-operated
group (M:939; p25:737; p75:1046). IR ? GPC (M:1228;
p25:1153; p75:1256) caused a significant elevation and
normalized the IR-induced reduction in RBCV by 15 min
of the reperfusion period. An increasing tendency was seen
in the GPC ? IR group (M:966; p25:774; p75:1280)
(Fig. 4).
Biochemical parameters
Superoxide production in the small intestine
The reactive oxygen species -producing capacity of the
small intestinal biopsy samples did not change in the sham-
operated animals. By 15 min of reperfusion, there was a
significant enhancement in the IR group (M:2019.4;
p25:1814.5; p75:2349.3) relative to the baseline value and
also the sham-operated group (M:1182.2; p25:1046.6;
Fig. 3 Superior mesenteric artery flow during the experiments. The
empty circles joined by a continuous line relate to the sham-operated
group, grey triangles to the ischaemia–reperfusion (IR) group, empty
diamonds to the glycerylphosphorylcholine (GPC)-pretreated group,
and empty squares to the GPC-post-treated group. Median values and
75th and 25th percentiles are given. *p \ 0.05 relative to the baseline
value (within groups); xp \ 0.05 relative to the sham-operated control
group
Fig. 4 Red blood cell velocity changes during the experiment. The
white box blot relates to the sham-operated group, the dark-grey box
plot to the ischaemia–reperfusion (IR) group, the striped box plot to
the glycerylphosphorylcholine (GPC)-pretreated group and the
checked box plot to the GPC-post-treated group. Median values and
75th and 25th percentiles are given. *p \ 0.05 relative to the baseline
value (within groups); #p \ 0.05 relative to the IR group
Fig. 5 Superoxide production in the small intestine. The white box
blot relates to the sham-operated group, the dark-grey box plot to the
ischaemia–reperfusion (IR) group, the striped box plot to the
glycerylphosphorylcholine (GPC)-pretreated group, and the checked
box plot to the GPC-post-treated group. Median values and 75th and
25th percentiles are given. *p \ 0.05 relative to the baseline value
(within groups)
Fig. 6 Xanthine oxidoreductase activity in the small intestine. The
white box blot relates to the sham-operated group, the dark-grey box
plot to the ischaemia–reperfusion (IR) group, the striped box plot to
the glycerylphosphorylcholine (GPC)-pretreated group, and the
checked box plot to the GPC-post-treated group. Median values and
75th and 25th percentiles are given. xp \ 0.05 relative to the sham-
operated control group; #p \ 0.05 relative to the IR group; @p \ 0.05
relative to the GPC-pretreated group
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p75:1340). Both GPC ? IR (M:958; p25:856; p75:1476)
and IR ? GPC treatment (M:1228; p25:839; p75:1568)
resulted in an appreciable reduction in the SOX level as
compared with the IR group. This tendency was maintained
until the end of the experiments (Fig. 5).
XOR activity in the small intestine
Xanthine oxidoreductase is activated during IR and pro-
duces a considerable amount of SOX. At the end of the
experiments, we observed a significantly higher XOR
activity in the IR animals (M:78.6; p25:67.7; p75:80.2)
than in the sham-operated ones (M:41.8; p25:27.3;
p75:55.9). The XOR activity was also significantly ele-
vated in the GPC ? IR group (M:78; p25:72; p75:84). In
contrast, the XOR activity was significantly lower in the
IR ? GPC group (M:19; p25:14; p75:21) than in either the
IR or the GPC ? IR groups. The IR ? GPC treatment
proved highly effective against reactive oxygen species -
producing mechanisms (Fig. 6).
Tissue nitrotyrosine level
Nitrotyrosine formation is a marker of nitrosative stress
within the tissues and correlates with peroxynitrite pro-
duction. IR resulted in a significant increase in nitrotyro-
sine level (M:2.6; p25:2.1; p75:3.1) relative to the control
group (M:1.4; p25:1.3; p75:1.8) at the end of the experi-
ment. In both the GPC ? IR (M:1.3; p25:1.05; p75:1.6)
and the IR ? GPC groups (M:1.5; p25:1.2; p75:1.57),
however, this increase did not take place, and the nitroty-
rosine content remained at the control level (Fig. 7).
ATP level in liver samples
In consequence of the outstanding generation of reactive
oxygen species in the mitochondria, at the end of the
reperfusion the ATP level in the IR group (M:1206.7;
p25:1093.5; p75:1521) was significantly lower than in the
sham-operated group (M:2025; p25:1775; p75:2232.5). As
compared with the IR group, there was a tendency to an
elevation in the GPC ? IR group (M:1690.8; p25:1410.3;
p75:1991.2) and a significantly higher ATP level in the
IR ? GPC group (M:1977.4; p25:1802.5; p75:2133.9). No
difference was detected between the levels in the
IR ? GPC and sham-operated groups (Fig. 8).
Discussion
The suppression of inflammation is of importance in the
control of a variety of human pathologies, and the main
goal of this study was to design and test potential therapies
with which to prevent or influence the short-term inflam-
matory consequences of an acute ischaemic challenge.
During ischaemia, the lack of electron-acceptor molecules
causes a redox imbalance [27], and the ensuing reoxy-
genation period is accompanied by harmful signs of
inflammatory activation. This phenomenon results in local
structural damage and circulatory deficiencies and also
leads to a great abundance of inflammatory mediators that
might cause distant or multiorgan failures [28].
In this study, intestinal IR decreased the mean arterial
pressure, the superior mesenteric artery flow and the
intramural RBCV, and increased the mesenteric vascular
resistance significantly. At the same time, the SOX, XOR,
Fig. 7 Nitrotyrosine level in the small intestine. The white box blot
relates to the sham-operated group, the dark-grey box plot to the
ischaemia–reperfusion (IR) group, the striped box plot to the
glycerylphosphorylcholine (GPC)-pretreated group, and the checked
box plot to the GPC-post-treated group. Median values and 75th and
25th percentiles are given. xp \ 0.05 relative to the sham-operated
control group; #p \ 0.05 relative to the IR group
Fig. 8 ATP level in liver samples. The white box blot relates to the
sham-operated group, the dark-grey box plot to the ischaemia–
reperfusion (IR) group, the striped box plot to the glycerylpho-
sphorylcholine (GPC)-pretreated group, and the checked box plot to
the GPC-post-treated group. Median values and 75th and 25th
percentiles are given. xp \ 0.05 relative to the sham-operated control
group; #p \ 0.05 relative to the IR group
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and nitrotyrosine levels were elevated significantly in the
small intestine, while the level of ATP in the liver was
reduced. Overall, these data furnish evidence concerning
the evolution of hypoxia/reoxygenation-induced and anti-
gen-independent inflammation.
The results also demonstrate that GPC treatment stabi-
lizes the RBCV in the intestinal wall and the macrocircu-
lation is also normalized. GPC administration exerted
pronounced effects on the inflammatory process by low-
ering SOX production and the activity of XOR, a prototype
of reactive oxygen species producing enzymes. Reactive
oxygen species are generated in the inflamed mucosa
mainly by the mitochondria, XOR, activated phagocytic
PMN leucocytes via the NADPH oxidase system and
uncoupled endothelial nitric oxide synthase (NOS). During
ischaemia, the synthesis of vasodilator NO is suppressed
due to the absence of the required co-factors, while at the
beginning of reoxygenation, a number of SOX-producing
enzymes, including XOR, become active, leading to per-
oxynitrite production [29]. The net result of these reactions
is the enhanced effect of vasoconstrictor mediators. Our
results clearly demonstrate the role of nitrosative stress and
the effectiveness of GPC in decreasing nitrotyrosine for-
mation. The data additionally indicate that GPC treatment
moderates the vasoconstrictive effects of IR. In this regard,
not only the macrocirculation, but also the microcirculatory
changes in the small intestine are influenced. Practically
speaking, we gained information on the intramural RBCV;
significantly reduced values were found in the IR group.
Due to the occlusion of a main perfusing artery, the tissue
microcirculation was impaired and recovery took a longer
time after the re-establishment of the blood flow. In con-
trast, the microperfusion was significantly improved in the
GPC-treated animals. Nevertheless, our results show that
the timing of GPC administration is a very important and,
perhaps, even critical issue. In the case of ROS (superox-
ide) production, there was a slight difference between the
effects of pre- and post-treatments at the end of the
experiment. These data correlated with the XOR activities,
where the level was significantly higher in the GPC-pre-
treated group than in the GPC-post-treated group.
Further, the ATP level of the liver was significantly
decreased in the sham-operated animals by the end of the
reperfusion, and a tendency for ATP production to increase
was seen in GPC-treated animals. These findings may be
linked to the membrane-conserving effect of GPC under
oxido-reductive stress conditions. A continuing lack of
oxygen will cause reductive stress with abnormally ele-
vated mitochondrial NADH/NAD? ratio and the collapse
of ionic homoeostasis, leading to dissipation of the trans-
membrane potential. During reoxygenation, the compo-
nents of the mitochondrial electron transport chain in the
inner membrane are main targets of reactive oxygen and
nitrogen species [30]. If prolonged, IR attacks lead to the
otherwise reversible damage of the mitochondrial electron
transport chain becoming irreversible, and functionless
membranes and embedded proteins cannot synthesize ATP.
Nevertheless, the mitochondrial electron transport chain- or
membrane-protective action of GPC, including the inhibi-
tion of mitochondrial reactive oxygen or nitrogen species
formation, demands further, in-depth investigations.
Choline-containing phospholipids in mammals are crit-
ically involved in maintaining the structural integrity and
the signalling functions of cellular membranes. PC is a
major source of the second messenger diacylglycerol,
phosphatidic acid, lysophosphatidic acid, and arachidonic
acid, which can be further metabolized to other signalling
molecules. The main pathways for PC-mediated hydrolysis
occur via phospholipases D, which produce choline and
phosphatidic acid, and phospholipases A1 and A2, which
generate free fatty acids and glycerol phosphocholine [31].
The subsequent hydrolysis of glycerol phosphocholine into
glycerol 3-phosphate, and choline is catalyzed by a
phosphodiesterase.
Our previous studies and other investigations have
characterized the anti-inflammatory properties of PC in
detail [13, 15, 20, 32–34]. In this line, it has been shown
that PC treatment can reduce reperfusion-caused damage
and increase the tolerance to hypoxia [20]. Other investi-
gators have demonstrated that PC is capable of moderating
the SOX production in PMN leucocytes, thereby inhibiting
the activated inflammatory reaction [35, 36]. In another
study, the degree of ATP depletion after IR was markedly
improved by PC treatment, and the activity of leucocytes
and the levels of pro-inflammatory mediator TNF-a gen-
eration and inducible NOS expression were reduced [15,
32].
The mechanism of action of GPC in IR-induced
inflammatory changes is still not fully understood, and
several possibilities should be taken into account. In the
present study, GPC administration resulted in identical
biological effects to those previously observed in similar
in vivo models and PC therapy involving an equimolar
dosage [20, 21]. This demonstrates indirectly that PC-
derived lipids do not participate in this action, and the data
suggest that the active component is the choline head
group. In this regard, GPC may possibly possess a mem-
brane-protective effect, promoting regenerative processes,
or conserving the double-lipid layer, thereby preserving the
original form and function of the cells. Indeed, previous
studies have revealed that GPC has a special role in neu-
rodegenerative processes [37]. It was previously shown
that GPC can ameliorate the neural function after traumatic
injuries [37, 38], acute ischaemic stroke and Alzheimer’s
disease [37, 39]. These findings tend to confirm the pre-
sumed precursor nature of GPC for the neurotransmitter
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acetylcholine, but also point to an effect on the re-synthesis
of cell membrane lipid molecules such as PC.
The stimulation of the a7 subunit of the nicotinic ace-
tylcholine receptors (a7 nAChRs) could also contribute to
the beneficial effects of GPC. Choline is a full agonist of
a7 nAChRs [40], and it has been shown that dietary sup-
plementation with choline results in selective increases in
the density of a7 nAChRs in multiple brain regions [41].
The action of choline as a direct-acting a7 nAChR agonist
may improve the cognitive outcome as this receptor is
expressed at high levels in the rodent hippocampus [42,
43]. Nevertheless, the emerging evidence suggests that the
a7 nAChRs may be important regulators of inflammation
in both the central nervous system and the periphery [44].
The study by Wang et al. [45] established a link between
the cholinergic activity of the vagus nerve and peripheral
inflammation, with central involvement of a7 nAChRs
expressed on macrophages. Electrical stimulation of the
vagus nerve causes a significant decrease in tumour
necrosis factor release from macrophages, and the effects
of vagal stimulation were blocked by administration of a7
antagonists, and absent in a7 knockout mice. Shytle et al.
[44] showed that exposure to acetylcholine or nicotine
reduces inflammatory markers following the administration
of lipopolysaccharide, and that this effect is blocked by a7
antagonists. Subsequent work established that vagus nerve
signalling inhibits cytokine activities and improves disease
endpoints in experimental models of IR, haemorrhagic
shock, myocardial ischaemia, and pancreatitis [46–49].
Various immunologically competent cells (e.g. lympho-
cytes and microglia) express a7 AChR, so there is currently
considerable interest in compounds that influence the
function of the cholinergic anti-inflammatory pathway
[50]. Whether GPC acts as a cholinergic precursor or a
receptor agonist in this setting remains to be elucidated.
Our laboratory earlier reported that PC metabolites with
an alcoholic moiety in the molecule (i.e. choline, N,N-
dimethylethanolamine, and N-methylethanolamine) inhib-
ited reactive oxygen species production both in vitro and
in vivo, and displayed an effectiveness proportional to the
number of methyl groups in the compounds. We furnished
further evidence that PC metabolites may inhibit the for-
mation of reactive oxygen species by activated PMN leu-
cocytes [51]. How PMNs respond to GPC treatments
requires further, in-depth, functional investigation with
these solutions. Nevertheless, in a previous investigation in
which we examined the effects of GPC in the sodium
azide-treated rat, GPC treatment prevented the increase in
myeloperoxidase activity, a marker of PMN leucocyte
accumulation. [52].
In summary, the results presented here clearly show that
exogenous GPC administration diminishes the multifacto-
rial macro- and microcirculatory dysfunction, and reduces
the reactive oxygen and nitrogen species production and
ATP depletion caused by an IR insult. In light of the above
discussion, these data provide further, indirect evidence
that the anti-inflammatory effects of PC may be linked to a
reaction involving the polar part of the molecule. It is clear
that additional investigations are required to analyse the
mechanistic effects of GPC, but it is conceivable that GPC
or GPC metabolites may be pivotal anti-inflammatory
factors if present in the inflammatory milieu.
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